Case Study

World’s Largest CRO Leverages Partnership With Integrated Central IBC to Initiate Sites in COVID-19 Vaccine Research at Warp Speed

IQVIA and Advarra partnered to advance Operation Warp Speed COVID-19 vaccine trials and deliver exemplary service to sponsors and clinical research sites.

The results:

  • IBC approval timelines reduced to under 2 working days
  • Participating sites approved 78% faster
  • Sites activated to “ready to enroll” 71% faster
  • Trial results delivered to sponsor quicker than expected

To learn more, download the case study.

Scroll to Top